Jeffrey Gudin, MD, is co-founder and Executive Vice President at Virpax. Dr. Gudin completed both an anesthesiology residency and pain management fellowship at Yale University School of Medicine, and has been active in the pain management space as a clinician, consultant and researcher for more than 25 years. He is Board Certified in Pain Medicine, Anesthesiology, Addiction Medicine and Hospice and Palliative Medicine. Dr. Gudin is on faculty at the University of Miami Miller School of Medicine in the Department of Anesthesiology, Perioperative Medicine and Pain Management. He has assisted in the development and marketing of numerous analgesics, and is currently principal investigator on an analgesic project awarded a grant through the National Center for Advancement of Translational Sciences at the NIH. He has presented at numerous national and international pain congresses, and has dedicated his career towards risk management and the development of safer, more effective pain medications.
Current role
EVP, Chief Medical Officer at Intellia Therapeutics
EVP, Chief Medical Officer at HeartFlow
EVP, Chief Medical Officer at UnitedHealth Group
EVP & Chief Medical Officer at Fairview Health Services
EVP, Chief Medical Officer at Seres Therapeutics
Access the worlds's biggest network of public org charts
Learn more